drugset / Trial / NCT05604989

Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration

NCT05604989 ↗

Phase 3 Completed 45 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

A pilot study for Associations between the oral and intestinal microbiome and neovascular age-related macular degeneration and the investigation on the effect of oral probiotics as a treatment The investigators recruit the neovascular AMD patients and control patients. 1. 15 neovascular AMD patients with anti-VEGF treatment and oral probiotics supplement 2. 15 neovascular AMD patients with anti-VEGF treatment and no oral probiotics supplement 3. 15 control patients and no oral probiotics supplement The investigators will collect stool, blood, and saliva sample at the baseline and 6 months, and analyze the oral and intestinal microbiome changes.

Timeline

Start
2023-01-01
Primary completion
2024-08-31
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Probiotic Combination Cap/Tab Other / unclassified — Oral